Replies to post #35438 on Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

Nothing would please me more than IPCI selling off part or all of their entire generics division to regain their Nasdaq listing requirements so that mgmt. can focus entirely on advancing their 2 NDA Candidates and PODRAS.

And if that turns out to be the case I bet Boyd/Armistice had a lot of influence on management making such a decision because I'm still shocked that Armistice holds such a large institutional position at this risky juncture in IPCI's journey! Boyd alone appears to be playing a much larger role/part in IPCI's future direction behind the scenes by simply holding onto their position than any of us may yet realize...and I for one hope it's due to his positive influence growing behind the scenes on a monthly basis.

I still believe Dr. Odidi is a brilliant scientist...he just needs the right guidance. He also needs to step aside and assume the Founder and Chief Scientific Officer titles and bring in a seasoned/qualified Bio CEO!

I still believe there's potential in IPCI if Dr. Odidi's finally reached the point where he's willing to accept that he can no longer continue wearing all the hats.

[wimike]

Let's hope if they are selling their generics they get full value not discounted.

[tilator]

Agreed mike. I now no longer think that tomorrows s/h of record date pertains to voting on any new BOD additions. But it could have to do with a potential discounted asset sale.

Maybe IPCI sells off their FocalinXR rights to PAR or SeroquelXR rights to MNK or sells off Glucophage to some other entity

They do not need extra meeting for that. They can just sell without asking us anything.